Agnieszka Chryplewicz

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• RADAR: differential analysis of MeRIP-seq data with a random effect model.⚑
  2019 L1 10/100 ⚑

1 assessed by us (0 reproduced) · 23 not yet assessed — every PubMed paper on record, linked below.

• Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence ↗

  Cancer Cell · 2024 · PMID 39255775
  not yet assessed
• Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages ↗

  Immunity · 2023 · PMID 36630914
  not yet assessed
• Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity ↗

  Cancer Cell · 2022 · PMID 36113478
  not yet assessed
• Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion ↗

  Science · 2022 · PMID 36395212
  not yet assessed
• Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion ↗

  2022
  not yet assessed
• Abstract B40: Co-targeting autophagy, macrophages and vasculature in glioma tumors triggers tumor immunity ↗

  Cancer Immunology Research · 2022
  not yet assessed
• Abstract B41: Reprogramming immunosuppressive tumor-associated macrophages potentiates standard-of-care therapy in melanoma ↗

  Cancer Immunology Research · 2022
  not yet assessed
• Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas ↗

  Gynecologic Oncology · 2021 · PMID 34452747
  not yet assessed
• Phosphonic Analogs of Alanine as Acylpeptide Hydrolase Inhibitors ↗

  Chemistry & Biodiversity · 2021 · PMID 33427376
  not yet assessed
• Germline mutations in Black women with ovarian, fallopian tube and primary peritoneal carcinomas ↗

  Gynecologic Oncology · 2021
  not yet assessed
• Cover Picture: Phosphonic Analogs of Alanine as Acylpeptide Hydrolase Inhibitors (Chem. Biodiversity 2/2021) ↗

  Chemistry & Biodiversity · 2021
  not yet assessed
• Abstract 1652: Co-targeting distinct hallmark capabilities for therapeutic benefit in pre-clinical GBM models ↗

  Cancer Research · 2021
  not yet assessed
• Co-targeting distinct hallmark capabilities for therapeutic benefit in pre-clinical GBM models.

  Cancer Research · 2021
  not yet assessed
• Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts ↗

  Nature · 2019 · PMID 31043742
  not yet assessed
• RADAR: differential analysis of MeRIP-seq data with a random effect model⚑

  Genome biology · 2019 · PMID 31870409
  L1 10/100 ⚑
• Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6 ↗

  Scientific Reports · 2019 · PMID 30914657
  not yet assessed
• Ultrasensitive, multiplexed chemoproteomic profiling with soluble activity-dependent proximity ligation ↗

  Proceedings of the National Academy of Sciences · 2019 · PMID 31591248
  not yet assessed
• ECCR1 and NFKB2 Polymorphisms as Potential Biomarkers of Non-small Cell Lung Cancer in a Polish Population ↗

  Anticancer Research · 2019 · PMID 31177178
  not yet assessed
• Metabolic reprogramming of the stromal epigenome in ovarian cancer metastasis ↗

  The FASEB Journal · 2019
  not yet assessed
• RADAR: Differential analysis of MeRIP-seq data with a random effect model ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2019
  not yet assessed
• m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer ↗

  Nature Cell Biology · 2018 · PMID 30154548
  not yet assessed
• Nicotinamide N-methyltransferase metabolically reprograms the stroma to promote ovarian cancer metastasis.

  Max Planck Digital Library · 2018
  not yet assessed
• Beta-escin inhibits ovarian cancer metastasis by targeting the tumor microenvironment.

  Max Planck Digital Library · 2018
  not yet assessed
• Abstract 5899: Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts ↗

  Cancer Research · 2017
  not yet assessed